CellPort software joins the tetra partner network to help customers accelerate cell development and manufacturing

TetraScience, the R&D Data Cloud company, announced today that CellPort Software, a SaaS company that digitizes workflows for cell development and manufacturing, has joined the Tetra Partner Network (TPN) to accelerate delivery of cell-based therapeutics. We welcome a partnership with CellPort, recognizing their crucial contribution to eliminating paper lab notebooks in cell manufacturing processes. CellPort

What are the Health Benefits of Cocoa?

Cocoa is most commonly associated with chocolate and has a variety of nutritional benefits that can confirm positive health attributes. The cocoa bean is an accident source of dietary polyphenols, containing more finale antioxidants than most foods. It is well known that polyphenols are associated with beneficial health effects, therefore cocoa is rich in polyphenols,

The cellular response that protects pigs from COVID-19

Iowa State University scientists may have uncovered an important clue that sheds light on why pigs don’t get sick when exposed to the coronavirus. Studies since the start of the pandemic have noted that pigs can be infected by the virus if exposed to high doses, but the infection is self-limited and pigs don’t show

More than 2 dozen drugmakers to make Merck’s COVID-19 pill

A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck’s COVID-19 pill to supply 105 developing countries. The Medicines Patent Pool said the deals would allow drug companies to make both the raw ingredients for molnupiravir and the finished product itself. Molnupiravir,

How nursing schools can forward nurse-led innovation

In order for nurses to lead in health and health care innovation, schools of nursing and nursing programs must think strategically about the knowledge and skills the next generation of nurses will need and then support those innovation needs at all levels of research, education, and practice.   An article recently published in the Journal of

Poor fidelity may mean effective education strategies never see light of day

Promising new education interventions are potentially being ‘unnecessarily scrapped’ because trials to test their effectiveness may be insufficiently faithful to the original research, a study has warned. The cautionary note is being raised after researchers ran a large-scale computer simulation of more than 11,000 research trials to examine how much ‘fidelity’ influenced the results. In

Stem Cell-Derived Pancreatic Cells for Type 1 Diabetes

NEW YORK (Reuters Health) – An ongoing first-in-human trial suggests that pancreatic cells grown from stem cells can be safely implanted into patients with type 1 diabetes, and in some cases, begin producing insulin. “I was surprised by how well the device implant and explant surgeries were tolerated by these patients, and to be able